CGNX Form 144: Insider sale of 61,900 shares listed

Company CGNX reported insider sale activity via a Form 144 notice.

Rhea-AI Filing Summary

Company CGNX reported insider sale activity via a Form 144 notice. The filing lists 61,900 common shares and an aggregate amount of $3,468,385.93 tied to 02/20/2026 on NASDAQ. The excerpt also shows 2,729 restricted shares dated 02/18/2026 and 59,171 shares from a stock option exercise dated 02/20/2026.

Insights

Insider Transactions Analyst

Form 144 lists insider disposal activity including 61,900 common shares and related transactions on 02/20/2026.

The filing entry shows $3,468,385.93 associated with 61,900 common shares and identifies the trading venue as NASDAQ. It separately records 2,729 restricted shares (dated 02/18/2026) and a 59,171 stock option exercise (dated 02/20/2026).

Cash‑flow treatment for the stock option exercise is shown as Cash. Timing and execution details beyond the listed dates are not provided in the excerpt; subsequent filings would show settlement or executed sale details.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions does CGNX report in this Form 144?

The filing reports sales-related activity including 61,900 common shares and an aggregate amount of $3,468,385.93. It also lists 2,729 restricted shares dated 02/18/2026 and a 59,171-share stock option exercise dated 02/20/2026 with cash indicated for the exercise.

When were the reported CGNX transactions dated?

Transaction dates shown are 02/18/2026 and 02/20/2026, with the primary sale entry on 02/20/2026. The restricted stock entry is dated 02/18/2026 and the stock option exercise is dated 02/20/2026, per the excerpt.

How much aggregate value is listed for the CGNX shares in the filing?

The excerpt lists an aggregate amount of $3,468,385.93 tied to the 61,900 common shares. The filing specifies that figure alongside the share count and the trade date of 02/20/2026 on NASDAQ.

Does the Form 144 excerpt show how the option exercise was settled?

Yes. The excerpt indicates the stock option exercise involving 59,171 shares on 02/20/2026 was settled for cash. No further settlement or subsequent sale details are provided in the provided excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/20/2026 - 05:17 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001938568
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	COGNEX CORPORATION
SEC File Number	001-34218
Address of Issuer	One Vision Drive Natick MASSACHUSETTS 01760-2059
Phone	(508) 650-3000
Name of Person for Whose Account the Securities are To Be Sold	JOERG KUECHEN
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	61900	3468385.93	165707920	02/20/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/18/2026	Restricted Stock	Issuer			2729	02/18/2026	Not Applicable
Common	02/20/2026	Stock Option Exercise	Issuer			59171	02/20/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	02/20/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Joerg Kuechen
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)